These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28620220)

  • 1. Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits.
    Bárcena-Varela S; Martínez-de-Tejada G; Martin L; Schuerholz T; Gil-Royo AG; Fukuoka S; Goldmann T; Droemann D; Correa W; Gutsmann T; Brandenburg K; Heinbockel L
    Exp Mol Med; 2017 Jun; 49(6):e345. PubMed ID: 28620220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.
    Heinbockel L; Marwitz S; Barcena Varela S; Ferrer-Espada R; Reiling N; Goldmann T; Gutsmann T; Mier W; Schürholz T; Drömann D; Brandenburg K; Martinez de Tejada G
    PLoS One; 2015; 10(7):e0133291. PubMed ID: 26197109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial Sepsis.
    Patel A; Joseph J; Periasamy H; Mokale S
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ceftriaxone resistance in Salmonella enterica serotype Oranienburg during therapy for bacteremia.
    Yang WC; Chan OW; Wu TL; Chen CL; Su LH; Chiu CH
    J Microbiol Immunol Infect; 2016 Feb; 49(1):41-5. PubMed ID: 24657069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5.
    Heinbockel L; Weindl G; Martinez-de-Tejada G; Correa W; Sanchez-Gomez S; Bárcena-Varela S; Goldmann T; Garidel P; Gutsmann T; Brandenburg K
    Front Immunol; 2018; 9():1704. PubMed ID: 30093904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors.
    Heinbockel L; Sánchez-Gómez S; Martinez de Tejada G; Dömming S; Brandenburg J; Kaconis Y; Hornef M; Dupont A; Marwitz S; Goldmann T; Ernst M; Gutsmann T; Schürholz T; Brandenburg K
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1480-7. PubMed ID: 23318793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Adamis T; Koussoulas V; Baziaka F; Perrea D; Karayannacos PE; Giamarellou H
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models.
    Hubsch AP; Casas AT; Doran JE
    J Lab Clin Med; 1995 Dec; 126(6):548-58. PubMed ID: 7490514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
    Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin and ceftriaxone combination treatment for relapsed Salmonella Paratyphi A bacteraemia.
    Oey M; Malhotra P
    J Travel Med; 2016 Feb; 23(2):tav032. PubMed ID: 26858276
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model.
    Sha T; Sunamoto M; Kitazaki T; Sato J; Ii M; Iizawa Y
    Eur J Pharmacol; 2007 Oct; 571(2-3):231-9. PubMed ID: 17632100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheal co-administration of antioxidants and ceftriaxone reduces pulmonary injury and mortality rate in an experimental model of sepsis.
    Galvão AM; Wanderley MS; Silva RA; Filho CA; Melo-Junior MR; Silva LA; Streck EL; Dornelas de Andrade AF; Souza Maia MB; Barbosa de Castro CM
    Respirology; 2014 Oct; 19(7):1080-7. PubMed ID: 25124169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of Sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock.
    Liang Q; Dong S; Lei L; Liu J; Zhang J; Li J; Duan J; Fan D
    Cytokine; 2015 Oct; 75(2):302-9. PubMed ID: 25573805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice.
    Lozano FS; García MI; García E; González B; García MB; García FJ; García JE
    Rev Esp Quimioter; 2009 Sep; 22(3):135-8. PubMed ID: 19662546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides.
    Martinez de Tejada G; Heinbockel L; Ferrer-Espada R; Heine H; Alexander C; Bárcena-Varela S; Goldmann T; Correa W; Wiesmüller KH; Gisch N; Sánchez-Gómez S; Fukuoka S; Schürholz T; Gutsmann T; Brandenburg K
    Sci Rep; 2015 Sep; 5():14292. PubMed ID: 26390973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain abscess caused by Salmonella enterica subspecies houtenae in a patient with chronic granulomatous disease.
    Ma JS; Chen PY; Lau YJ; Chi CS
    J Microbiol Immunol Infect; 2003 Dec; 36(4):282-4. PubMed ID: 14723260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.